Are you in %country%? Do you want to visit our website in another language?

¿Está en España? ¿Desea ver nuestra página web en otro idioma?

Вы находитесь в %country%? Открыть наш сайт на другом языке?

Êtes-vous en France ? Aimeriez-vous visiter notre site Web dans une autre langue ?

日本にいますか 私たちのウェブサイトを別の言語で訪問したいですか?

Befinden Sie sich in %country%? Möchten Sie unsere Website in einer anderen Sprache anzeigen?

Você esta no %country%? Deseja visitar nosso site em outro idioma?

您在中国吗? 您是否想访问我们其他语言版本的网站?

Newsroom

Adaptive Hybrid Surgery Receives FDA Clearance

December 22, 2014

BALANCE SURGICAL RISK WITH RADIOSURGICAL TOXICITY

Brainlab announced 510(k) clearance for revolutionary software, Adaptive Hybrid Surgery. After successful clinical use in several international markets, Adaptive Hybrid Surgery is now available in the United States.

Built with neurosurgeons in mind, Adaptive Hybrid Surgery helps physicians to balance surgical risk with radiosurgical toxicity for multi-disciplinary treatment of skull-base tumors. A complete set of automated tools enables continuous analysis of adjuvant radiosurgery at any time, while planning and performing a surgical resection.

• On-the-fly feasibility analysis of adjuvant radio surgery
• Complete treatment workflow from planning to intraoperative decision making
• Support of interdisciplinary collaboration
• Upfront integration of radiosurgery avoiding late referrals and potentially restricted treatment options

Click here to learn more about Adaptive Hybrid Surgery.